10 Best Small-Cap Stocks to Buy Before They Explode
Since the announcement of tariffs, investors have been concerned regarding the market volatility.
Agios Pharmaceuticals Inc. (AGIO)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Farallon Capital Thomas Steyer | 5,674,466 | $186,462,953 | +1% | 0.94% |
| 2. | Armistice Capital Steven Boyd | 2,264,304 | $74,405,029 | +3% | 1.01% |
| 3. | Leucadia National Ian Cumming And Joseph Steinberg | 1,500,000 | $49,290,000 | 0.3% | |
| 4. | Citadel Investment Group Ken Griffin | 1,433,676 | $47,110,594 | +12117% | 0% |
| 5. | Biotechnology Value Fund / BVF Inc Mark Lampert | 1,073,755 | $35,283,589 | -10% | 1.19% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $31.00 | 40,322 | Officer, Director | 41,722 | 2019-11-13 | Filing | |
| $31.00 | 8,064 | Director | 97,567 | 2019-11-13 | Filing | |
| $31.00 | 403,225 | Large Shareholder | 1,777,824 | 2019-11-12 | Filing | |
| $83.44 | 200 | Director | 571 | 2018-03-16 | Filing | |
| $67.00 | 851,154 | Large Shareholder | 1,374,599 | 2018-01-23 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $25.90 | 7,497 | Director | 149,220 | 2025-04-10 | Filing | |
| $35.54 | 1,681 | Officer | 25,449 | 2025-03-03 | Filing | |
| $35.54 | 1,187 | Officer | 21,463 | 2025-03-03 | Filing | |
| $35.54 | 1,137 | Officer | 18,650 | 2025-03-03 | Filing | |
| $35.54 | 1,681 | Officer | 25,829 | 2025-03-03 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 86,842 | $2,544,459 | 0% | |
| 2. | 1,917 | $58,047 | 0% | |
| 3. | 504 | $14,767 | 0% | |
| 4. | 361 | $10,577 | 0.01% | |
| 5. | 279 | $8,175 | 0% |
News See All
10 Best Small-Cap Stocks to Buy Now
The S&P 500 index has reached its all-time highs, achieving returns of over 20% for two second consecutive years post-COVID.
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q4 2024 Earnings Call Transcript
Operator: Good morning, and welcome to Agios' Fourth Quarter 2024 Conference Call. [Operator Instructions] Please be advised that this call is being recorded at Agios' request.
10 Cheap Biotech Stocks to Invest in Now
Biotechnology stocks are among the most volatile in the market due to their high risk.
Top 10 Small Cap Stocks to Buy with the Highest Upside Potential
On December 30, MJP Wealth Advisors chief investment officer Brian Vendig appeared on Yahoo! Finance's Catalysts to discuss the potential outlook of small cap stocks in 2025.
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q3 2024 Earnings Call Transcript
Operator: Good morning, and welcome to Agios' Third Quarter 2024 Conference Call. [Operator Instructions] Please be advised that today's call is being recorded at Agios' request.
Agios Pharmaceuticals (AGIO) Appreciated after Positive Testing Results
Meridian Funds, managed by ArrowMark Partners, released its “Meridian Growth Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
Top 10 Holdings of Caligan Partners
Founded in 2017, Caligan Partners is one of the most significant specialty hedge funds.
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q2 2024 Earnings Call Transcript
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q2 2024 Earnings Call Transcript August 1, 2024Agios Pharmaceuticals, Inc. misses on earnings expectations.
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q1 2024 Earnings Call Transcript
Operator: Good morning, and welcome to Agios’ First Quarter 2024 Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded at Agios’ request.
Billionaire Hedge Funds
